Niell HB - Search Results

1

Pharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer.

Miller AA, Tolley EA, Niell HB, Griffin JP, Mauer AM. Miller AA, et al. Among authors: niell hb. J Clin Oncol. 1993 Jun;11(6):1179-88. doi: 10.1200/JCO.1993.11.6.1179. J Clin Oncol. 1993. PMID: 8388920

2

Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732.

Niell HB, Herndon JE 2nd, Miller AA, Watson DM, Sandler AB, Kelly K, Marks RS, Perry MC, Ansari RH, Otterson G, Ellerton J, Vokes EE, Green MR; Cancer and Leukemia Group. Niell HB, et al. J Clin Oncol. 2005 Jun 1;23(16):3752-9. doi: 10.1200/JCO.2005.09.071. J Clin Oncol. 2005. PMID: 15923572 Clinical Trial.

3

Pharmacodynamics of three daily infusions of etoposide in patients with extensive-stage small-cell lung cancer.

Miller AA, Tolley EA, Niell HB, Stewart CF, Griffin JP. Miller AA, et al. Among authors: niell hb. Cancer Chemother Pharmacol. 1992;31(2):161-6. doi: 10.1007/BF00685105. Cancer Chemother Pharmacol. 1992. PMID: 1333371

4

Combination versus sequential single-agent chemotherapy in the treatment of patients with advanced non-small cell lung cancer.

Niell HB, Griffin JP, Hunter RF, Meredith CA, Somes G. Niell HB, et al. Med Pediatr Oncol. 1989;17(1):69-75. doi: 10.1002/mpo.2950170115. Med Pediatr Oncol. 1989. PMID: 2536462 Clinical Trial.

5

5-Fluorouracil infusion and mitomycin combination chemotherapy in the management of patients with advanced non-small-cell lung cancer.

Weir AB 3rd, Niell HB, Griffin JP. Weir AB 3rd, et al. Among authors: niell hb. Am J Clin Oncol. 1989 Dec;12(6):521-3. doi: 10.1097/00000421-198912000-00013. Am J Clin Oncol. 1989. PMID: 2556013

6

Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer.

Niell HB, Griffin JP. Niell HB, et al. Med Pediatr Oncol. 1985;13(6):341-5. doi: 10.1002/mpo.2950130608. Med Pediatr Oncol. 1985. PMID: 3930930

7

Phase II study of prolonged oral etoposide in combination with intravenous cisplatin in advanced non-small cell lung cancer.

Miller AA, Niell HB, Griffin JP. Miller AA, et al. Among authors: niell hb. Lung Cancer. 1995 Mar;12(1-2):59-65. doi: 10.1016/0169-5002(94)00406-d. Lung Cancer. 1995. PMID: 7600031 Clinical Trial.

8

Therapeutic drug monitoring of 21-day oral etoposide in patients with advanced non-small cell lung cancer.

Miller AA, Tolley EA, Niell HB. Miller AA, et al. Among authors: niell hb. Clin Cancer Res. 1998 Jul;4(7):1705-10. Clin Cancer Res. 1998. PMID: 9676845

9

Phase I and pharmacologic study of sequential topotecan, carboplatin, and etoposide.

Miller AA, Niell HB. Miller AA, et al. Among authors: niell hb. Lung Cancer. 2001 Aug-Sep;33(2-3):241-8. doi: 10.1016/s0169-5002(00)00246-4. Lung Cancer. 2001. PMID: 11551419 Clinical Trial.

10

Diagnosis of lung cancer: a bronchoscopist's perspective.

Griffin JP, Zaman MK, Niell HB, Tolley EA, Cole FH Jr, Weiman DS. Griffin JP, et al. Among authors: niell hb. J Bronchology Interv Pulmonol. 2012 Jan;19(1):12-8. doi: 10.1097/LBR.0b013e3182425b5d. J Bronchology Interv Pulmonol. 2012. PMID: 23207257

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters